This double-blind study determined whether consumption of a Lactobacillus reuteri strain harbouring a plasmid containing the tetracycline resistance gene resulted in a detectable tetracycline resistance signal in faecal bacteria including enterococci, bifidobacteria and lactobacilli.

Subjects consumed either an Lactobacillus reuteri strain harbouring the tetracycline resistance gene (ATCC 55730) (n=7) or a control strain (n=7) from which the plasmid had been removed (DSM 17938).

For both arms of the study the Lactobacillus reuteri dose was 5 x 10^8 CFU/day for 14 days. Both strains were detectable at similar levels in the faeces but no tetracycline resistance signal was detected in any of the bacterial DNA samples collected.

Conclusion: Gene transfer during intestinal passage of the probiotic strain Lactobacillus reuteri ATCC 55730 was non-detectable under the conditions tested.

 

Reference

Egervärn M, Lindmark H, Olsson J, Roos S. Transferability of a tetracycline resistance gene from probiotic Lactobacillus reuteri to bacteria in the gastrointestinal tract of humans. Epub 2009 Dec 8. 2010;97(2):189-200.

Crawling baby

For the avoidance of doubt, BioGaia’s products are food supplements, and the information on this part of the website should not be interpreted as our products are intended to diagnose, treat, cure or prevent any disease.

The information on this part of the website is intended only for health care and business professionals. If you are not a health care or business professional and would like to learn more about the indications BioGaia works with, please visit our Expertise pages.

Please read terms & conditions before accepting. By clicking on the button “I acknowledge and accept” you confirm that you are a healthcare or business professional and have read and understood this disclaimer including the terms and conditions.